Literature DB >> 3300424

Epidural ketamine for postoperative pain relief after gynecologic operations: a double-blind study and comparison with epidural morphine.

Y Kawana, H Sato, H Shimada, N Fujita, Y Ueda, A Hayashi, Y Araki.   

Abstract

This double-blind study evaluates whether ketamine given epidurally is effective for postoperative pain relief, and compares the effects of epidural ketamine with those of epidural morphine. Sixty-eight patients undergoing abdominal gynecologic surgery were randomly assigned into six groups (control; ketamine 4, 6, and 8 mg in saline; 6 mg in 10% glucose; morphine 3 mg). All patients were anesthetized with thiopental, nitrous oxide, and enflurane, and drugs were administered epidurally at the end of the operation. The duration of analgesia in the ketamine groups did not differ from that in control patients and the difference in diluent had no observable effects. Significantly, none of the patients in the morphine group needed additional analgesics within 24 hr, whereas 85% in the other five groups did. We conclude that ketamine administered epidurally is inadequate for postoperative pain relief after gynecologic operations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300424

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain.

Authors:  C Y Yang; C S Wong; J Y Chang; S T Ho
Journal:  Can J Anaesth       Date:  1996-04       Impact factor: 5.063

2.  The Epidural and Intrathecal Administration of Ketamine.

Authors: 
Journal:  Curr Rev Pain       Date:  1999

3.  [Intrathecal and epidural administration of non-opioid analgesics in acute and chronic pain treatment.].

Authors:  B Donner; M Tryba; M Zenz; M Strumpf
Journal:  Schmerz       Date:  1994-06       Impact factor: 1.107

Review 4.  Ketamine: an update on the first twenty-five years of clinical experience.

Authors:  D L Reich; G Silvay
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.